TUPINI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 273
NA - Nord America 269
AS - Asia 131
Totale 673
Nazione #
US - Stati Uniti d'America 268
IT - Italia 195
SG - Singapore 53
CN - Cina 34
ID - Indonesia 21
DE - Germania 19
PL - Polonia 16
SE - Svezia 15
HK - Hong Kong 14
GB - Regno Unito 8
CH - Svizzera 6
FR - Francia 4
IN - India 4
RO - Romania 3
FI - Finlandia 2
LT - Lituania 2
VN - Vietnam 2
CA - Canada 1
IE - Irlanda 1
JP - Giappone 1
KR - Corea 1
PH - Filippine 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 673
Città #
Ferrara 57
Singapore 43
Santa Clara 35
Ashburn 29
Fairfield 22
Chandler 21
Jakarta 21
Milan 17
Shanghai 16
Warsaw 16
Beijing 14
Hong Kong 14
Addison 12
Bologna 9
Bremen 8
Houston 8
Munich 8
Wilmington 8
Cambridge 7
Princeton 7
Ferrara di Monte Baldo 6
Seattle 6
Woodbridge 6
Zurich 5
Ann Arbor 4
Botricello 4
Cagliari 4
London 4
Naples 4
New York 4
Rome 4
Frankfurt am Main 3
Los Angeles 3
Parma 3
Reggio Calabria 3
Reggio Emilia 3
San Diego 3
Alzano Lombardo 2
Cesena 2
Des Moines 2
Dong Ket 2
Florence 2
Fossano 2
Granarolo dell'Emilia e Viadagola 2
Lissone 2
Mira 2
New Delhi 2
Padova 2
Pescara 2
Pignataro Maggiore 2
Povegliano Veronese 2
Santa Maria a Vico 2
Sirolo 2
Trento 2
Vercelli 2
Villejuif 2
Washington 2
Bari 1
Besenello 1
Capriate San Gervasio 1
Dublin 1
Falls Church 1
Gravina in Puglia 1
Guangzhou 1
Guarda Veneta 1
Helsinki 1
Hounslow 1
Lappeenranta 1
Leawood 1
Muggia 1
Nerviano 1
Norwalk 1
Ottawa 1
Redwood City 1
Sala Baganza 1
Senhora Da Hora 1
Southwark 1
Stoughton 1
Talavera 1
Telese 1
Tokyo 1
Trieste 1
Wandsworth 1
Totale 507
Nome #
New anti-inflammatory agents targeting Nuclear Factor kappa B (NF-kB) in the treatment of Cystic Fibrosis 102
Palladium (0) olefin complexes bearing purine-based N-heterocyclic carbenes and 1,3,5-triaza-7-phosphaadamantane (PTA): Synthesis, characterization and antiproliferative activity toward human ovarian cancer cell lines 97
Pro‑apoptotic activity of novel synthetic isoxazole derivatives exhibiting inhibitory activity against tumor cell growth in vitro 69
New synthetic isoxazole derivatives as potent inducer of fetal hemoglobin (HbF) in beta-thalassemia 64
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 60
A peptide nucleic acid targeting the acpP gene of Pseudomonas aeruginosa inhibits bacterial induced biological alterations in cystic fibrosis cells 56
Up-regulation of miR-34a-3p and miR-744-3p is associated with down-regulation of PTEN in lymphoblastoid cells from Shwachman-Diamond Syndrome patients 50
Xylitol as a Hydrophilization Moiety for a Biocatalytically Synthesized Ibuprofen Prodrug 40
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening 34
Multifunctional Profiling of Moringa oleifera Leaf Extracts for Topical Application: A Comparative Study of Different Collection Time 34
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease 30
Design, Synthesis and Evaluation of New Multifunctional Benzothiazoles as Photoprotective, Antioxidant and Antiproliferative Agents 26
Bi-allelic expression of the RyR1 p.A4329D mutation decreases muscle strength in slow-twitch muscles in mice 25
Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221-3p and miR-222-3p: Synergistic Effects on Apoptosis 21
New Synthetic Isoxazole Derivatives Acting as Potent Inducers of Fetal Hemoglobin in Erythroid Precursor Cells Isolated from β-Thalassemic Patients 12
Synthesis and Biological Activity Assessment of 2-Styrylbenzothiazoles as Potential Multifunctional Therapeutic Agents 5
Totale 725
Categoria #
all - tutte 5.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 0 0 0 7 4 5 6 10 4 17 4
2020/202178 15 2 0 3 7 8 15 5 9 5 5 4
2021/2022102 1 5 0 1 8 2 27 6 5 7 15 25
2022/202395 8 10 4 5 13 4 13 7 6 3 13 9
2023/2024213 8 21 3 5 31 24 21 18 15 19 12 36
2024/2025180 27 17 49 41 46 0 0 0 0 0 0 0
Totale 725